Cabaletta Bio share price today

(CABA)

Cabaletta Bio share price is $2.34 & ₹199.36 as on 25 Dec 2024, 2.30 'hrs' IST

$2.34

▲

-0.02

(-0.85%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Cabaletta Bio share price in Dollar and Rupees. Guide to invest in Cabaletta Bio from India. Also see the sentimental analysis on Indian investors investing in Cabaletta Bio. Get details on the Indian mutual funds that are investing in Cabaletta Bio. Get Analyst recommendations and forecasts along with all the Cabaletta Bio's financials.

Cabaletta Bio share price movements

Today's Low: $2.23
Today's High: $2.38
$2.34
4.7%
Downside
Day's Volatility :6.3%
Upside
1.68%
52 Weeks Low: $1.76
52 Weeks High: $26.35
$2.34
24.79%
Downside
52 Weeks Volatility :93.32%
Upside
91.12%

Cabaletta Bio Returns

Period	Cabaletta Bio Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-41.35%	-9.0%	0.0%
6 Months	-68.12%	-4.6%	0.0%
1 Year	-89.98%	3.0%	0.0%
3 Years	-43.07%	0.0%	-21.1%

Cabaletta Bio Key Statistics

in dollars & INR

Previous Close	$2.36
Open	$2.38
Today's High	$2.38
Today's Low	$2.23
Market Capitalization	$114.4M
Today's Volume	$1.1M
52 Week High	$26.35
52 Week Low	$1.76
Revenue TTM	$0.0
EBITDA	$-98.6M
Earnings Per Share (EPS)	$-2.16
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-48.16%

How to invest in Cabaletta Bio from India?

It is very easy for Indian residents to invest directly in Cabaletta Bio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cabaletta Bio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cabaletta Bio or CABA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cabaletta Bio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cabaletta Bio shares which would translate to 0.364 fractional shares of Cabaletta Bio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cabaletta Bio, in just a few clicks!

Returns in Cabaletta Bio for Indian investors in Rupees

Investment Value

₹1,00,000

Cabaletta Bio investment value today

Current value as on today

₹12,256

Returns

₹87,744

(-87.74%)

Returns from Cabaletta Bio Stock

₹89,983 (-89.98%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Cabaletta Bio

409.52%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Cabaletta Bio from India has grown in the last 30 days as on Dec 26, 2024. 409.52% more purchase transactions for Cabaletta Bio in the last 30 days versus the previous period.

182%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Cabaletta Bio on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 182% more investors are searching Cabaletta Bio in the last 30 days versus the previous period.

Global Institutional Holdings in Cabaletta Bio

Jennison Associates LLC
11.52%
BlackRock Inc
9.73%
Fred Alger Management, LLC
8.43%
T. Rowe Price Investment Management,Inc.
7.52%
Adage Capital Partners Gp LLC
6.21%
Bain Capital Life Sciences Investors, LLC
5.65%

Analyst Recommendation on Cabaletta Bio

Buy

94%Buy

5%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Cabaletta Bio(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cabaletta Bio

What analysts predicted

Upside of 780.34%

Current:

$2.34

Target:

$20.60

Insights on Cabaletta Bio

Price Movement
In the last 3 months, CABA stock has moved down by -41.4%
CABA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 117.2%
CABA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 70.0%

Cabaletta Bio Technicals Summary

Sell

Neutral

Buy

Cabaletta Bio is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cabaletta Bio Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cabaletta Bio Inc	-3.31%	-68.12%	-89.98%	-43.07%	-83.27%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cabaletta Bio Inc	NA	NA	NA	-2.35	-0.48	-0.31	NA	4.94
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cabaletta Bio Inc	Buy	$114.4M	-83.27%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Cabaletta Bio

cabaletta bio, inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered t cell therapies for patients with b cell-mediated autoimmune diseases. its proprietary technology utilizes chimeric autoantibody receptor (caar) t cells that are designed to selectively bind and eliminate b cells, which produce disease-causing autoantibodies or pathogenic b cells. the company's lead product candidate is dsg3-caart, which is in phase i clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and hemophilia a with factor viii alloantibodies. its product candidate pipeline also include musk-caart, a preclinical stage product to treat a subset of patients with myasthenia gravis; fviii-caart, a discovery stage product to treat a subset of patients with hemophilia a; and dsg3/1-caart, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. cabaletta bio, inc. has a collaboration with the un

Organization	Cabaletta Bio
Employees	136
CEO	Dr. Steven A. Nichtberger M.D.
Industry	Health Technology

Management People of Cabaletta Bio

Name	Title
Dr. Steven A. Nichtberger M.D.	Co-Founder, Chairman, CEO & President
Dr. David J. Chang FACR, M.D., M.P.H.	Chief Medical Officer
Dr. Gwendolyn K. Binder Ph.D.	President of Science & Technology
Dr. Michael C. Milone M.D., Ph.D.	Co-Founder & Co-Chair of Scientific Advisory Board
Dr. Aimee Payne M.D., Ph.D.	Co-Founder & Co-Chair of Scientific Advisory Board
Mr. Anup Marda M.B.A.	Chief Financial Officer
Dr. Qing Sarah Yuan Ph.D.	Chief Technology Officer
Dr. Samik Basu M.D.	Chief Scientific Officer
Mr. Michael Gerard J.D.	General Counsel & Secretary
Ms. Heather Harte-Hall M.Sc.	Chief Compliance Officer

Important FAQs about investing in Cabaletta Bio from India :

What is Cabaletta Bio share price today?

Cabaletta Bio share price today stands at $2.34, Open: $2.38 ; Previous Close: $2.36 ; High: $2.38 ; Low: $2.23 ; 52 Week High: $26.35 ; 52 Week Low: $1.76. The stock opens at $2.38, after a previous close of $2.36. The stock reached a daily high of $2.38 and a low of $2.23, with a 52-week high of $26.35 and a 52-week low of $1.76.

Can Indians buy Cabaletta Bio shares?

Yes, Indians can invest in the Cabaletta Bio (CABA) from India.

With INDmoney, you can buy Cabaletta Bio at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cabaletta Bio at zero transaction cost.

How can I buy Cabaletta Bio shares from India?

It is very easy to buy Cabaletta Bio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cabaletta Bio be purchased?

Yes, you can buy fractional shares of Cabaletta Bio with INDmoney app.

What are the documents required to start investing in Cabaletta Bio stocks?

To start investing in Cabaletta Bio, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.